Evelo Biosciences, Inc. (EVLO) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts EVLO Hot Sheet
Join SI Premium – FREE
Evelo Biosciences, Inc. (NASDAQ: EVLO) reported Q4 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Evelo Biosciences, Inc. (EVLO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
